Frontlight ResearchEarly access
What researchers published on Friedreich ataxia
1,098 papers, newest first.
Showing 20 of 29
Trial resultAAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia: A Nonrandomized Clinical Trial.JAMA cardiology
Randomised trialSafety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.The Lancet. Neurology
In plain wordsRead moreRead the paper on PubMedRandomised trialDifferential Effects of Cerebellar Transcranial Direct Current Stimulation with Gait Training on Functional Mobility, Balance, and Ataxia Symptoms.Cerebellum (London, England)
Randomised trialSafety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI-1601) in Friedreich's ataxia.Annals of clinical and translational neurology
Randomised trialAnodal Cerebellar Transcranial Direct Current Stimulation Reduces Motor and Cognitive Symptoms in Friedreich's Ataxia: A Randomized, Sham-Controlled Trial.Movement disorders : official journal of the Movement Disorder Society
Randomised trialDouble blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia.Journal of neurology
Randomised trialEfficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe Extension.Movement disorders : official journal of the Movement Disorder Society
Trial resultA natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol.PloS one
Trial resultAn open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich's ataxia.Nature communications
Randomised trialResults of a randomized double-blind study evaluating luvadaxistat in adults with Friedreich ataxia.Annals of clinical and translational neurology
Trial resultProtocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA).Neurological research and practice
Randomised trialSafety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study).Annals of neurology
Trial resultSafety and efficacy of (+)-epicatechin in subjects with Friedreich's ataxia: A phase II, open-label, prospective study.Journal of inherited metabolic disease
Randomised trialPharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates.Drug design, development and therapy
Randomised trialRandomized, double-blind, placebo-controlled study of interferon-γ 1b in Friedreich Ataxia.Annals of clinical and translational neurology
Randomised trialPatient-reported outcomes in Friedreich's ataxia after withdrawal from idebenone.Acta neurologica Scandinavica
Randomised trialSafety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia.Annals of clinical and translational neurology
Trial resultAutomated functional upper limb evaluation of patients with Friedreich ataxia using serious games rehabilitation exercises.Journal of neuroengineering and rehabilitation
Randomised trialDouble-blind, randomized and controlled trial of EPI-743 in Friedreich's ataxia.Neurodegenerative disease management
Randomised trialRandomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia.Movement disorders : official journal of the Movement Disorder Society